Transgene Biotek
Compliance-57 (5) intimation after the end of quarter
Earlier from Transgene Biotek
- Compliance-57 (4): Prior intimation to the beginning of the quarter
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Transgene Biotek Limited. Press Release Sep 25 2026